Contemporary strategies to preserve renal function during cardiac and vascular surgery

Reviews in Cardiovascular Medicine

Volumn 4, Issue SUPPL. 1, 2003, Pages

  Sheinbaum, Roy ^a   Ignacio, Craig ^a   Safi, Hazim J ^a   Estrera, Anthony ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Acute renal failure; Cardiovascular surgery; Fenoldopam; Perioperative renal protection; Selective dopamine 1 receptor agonist; Thoracoabdominal aortic aneurysm

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FENOLDOPAM; MANNITOL; OXYGEN; PROSTAGLANDIN; SCAVENGER;

ABDOMINAL AORTA ANEURYSM; ACUTE KIDNEY FAILURE; ANEURYSM SURGERY; ARTICLE; ATTENUATION; CARDIOVASCULAR SURGERY; CONTROLLED STUDY; DIALYSIS; DRUG USE; ELECTIVE SURGERY; GLOMERULUS; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY PERFUSION; KIDNEY TUBULE; LENGTH OF STAY; MEDICAL RECORD; OXYGEN CONSUMPTION; PATHOGENESIS; POSTOPERATIVE COMPLICATION; REPERFUSION INJURY; SURGICAL MORTALITY; THORACIC AORTA ANEURYSM; TREATMENT OUTCOME; URINARY TRACT OBSTRUCTION; VASOCONSTRICTION; VASODILATATION;

CARDIOVASCULAR SURGICAL PROCEDURES; DOPAMINE AGONISTS; HUMANS; KIDNEY FAILURE, ACUTE; PHENOPERIDINE; TREATMENT OUTCOME; URINARY TRACT PHYSIOLOGY;

EID: 0037240048     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sladen RN, Prough DS. Perioperative renal protection. Probl Anesth. 1997;9:314-331.
2. Levy EM, Viscoli CM, Horowitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 1996;275:1489-1494.
3. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128:194-203.
4. Aronson S, Blumenthal R. Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J Cardiothorac Vasc Anesth. 1998;12:567-586.
5. Godet G, Fieron MH, Vicaut E, et al. Risk factors for acute postoperative renal failure In thoracic or thoracoabdominal aortic surgery: a prospective study. Anesth Analg. 1997;85:1227-1232.
6. Wilkes BM, Mailloux LU. Acute renal failure: pathogenesis and prevention. Am J Med. 1986;80:1129-1136.
7. Biebuyck JF, Gelman S. The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology. 1995;82:1026-1060.
8. Carriere S. Factors affecting renal cortical blood flow: a review. Can J Physiol Pharmacol. 1975;53:1-20.
9. Kien ND, Moore PG, Jaffe RS. Cardiovascular function during induced hypotension by fenoldopam or sodium nitorprusside in anesthetized dogs. Anesth Analg. 1992;74:72-78.
10. Safi HJ, Harlin SA, Miller CC, et al. Predictive factors for acute renal failure in thoracic and thoracoabdominal aortic aneurysm surgery. J Vasc Surg. 1996;24:338-345.
11. Novis BK, Roizen MF, Aronson S, Thisted RA. Association of preoperative risk factors with postoperative acute renal failure. Anesth Analg. 1994;78:143-149.
12. Lokhandwala MF, Amenta F. Anatomical distribution and function of dopamine receptors in the kidney. FASEB J. 1991;5:3023-3030.
13. Frishman WH, Hotchkiss H. Selective and nonselective dopamine receptor agonists: an innovative approach to cardiovascular disease treatment. Am Heart J. 1996;132:861-870.
14. Perdue PW, Balser JR, Lipsett PA, Breslow MJ. "Renal dose" dopamine in surgical patients: dogma or science? Ann Surg. 1998;227:470-473.
15. Singer I, Epstein M. Potential of dopamine A-1 agonists in the management of acute renal failure. Am J Kidney Dis. 1998;31:743-755.
16. McCrory C, Cunningham AJ. Low-dose dopamine: will there ever be a scientific rationale? [editorial]. Br J Anaesth. 1997;78:350-351.
17. Garwood S, Hines R, Harris S. Does dopamine exacerbate renal ischemia? Anesth Analg. 1999;88:SCA9.
18. Brooks DP, Drutz DJ, Ruffolo RR Jr. Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam. J Pharmacol Exp Ther. 1990;254:375-379.
19. Jorkasky DK, Audet P, Shusterman N, et al. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients. Am J Kidney Dis, 1992;19:567-572.
20. Garwood S, Hines R. Perioperative renal preservation: dopexamine and fenoldopam: new agents to augment renal performance. Semin Anesth. 1998;17:308-318.
21. Mathur VS, Carey RM, O'Connell DP. Renal and systemic hemodynamic effects of very low dose fenoldopam in normotensive subjects. Anesth Analg. 1999;88:SCA85.
22. Chiolero R, Borgeat A, Fisher A. Postoperative arrhythmias and risk factors after open heart surgery. Thorac Cardiovasc Surg. 1991;39:81-84.
23. Germann R, Hasibeder W, Haisjackl M, et al. Dopamine-1 receptor stimulation and mucosal tissue oxygenation in the porcine jejunum. Crit Care Med. 1995;23:1560-1566.
24. Shi Y, Zalewski A, Bravette B. Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine. Am Heart J. 1992;124:418-423.
25. Hill AJ, Feneck RO, Walesby RK. A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery. J Cardiothorac Vasc Anesth. 1993;7:279-284.